IMP
Process View
cellular response to glucose stimulus
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucose stimulus.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "cellular response to glucose stimulus"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 and major histocompatibility complex, class II, DR beta 1 | 0.502 | ||
| CCNY | cyclin Y | 0.393 | ||
| PLAU | plasminogen activator, urokinase | 0.375 | Rat | |
| NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.268 | ||
| MAFA | v-maf musculoaponeurotic fibrosarcoma oncogene homolog A (avian) | 0.266 | ||
| SNAP23 | synaptosomal-associated protein, 23kDa | 0.236 | ||
| HLA-DMA | major histocompatibility complex, class II, DM alpha | 0.193 | ||
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.179 | ||
| HLA-DRA | major histocompatibility complex, class II, DR alpha | 0.165 | ||
| AXL | AXL receptor tyrosine kinase | 0.150 | ||
| RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.146 | ||
| IL1B | interleukin 1, beta | 0.131 | Rat | |
| IL1R1 | interleukin 1 receptor, type I | 0.125 | Rat | |
| NAPA | N-ethylmaleimide-sensitive factor attachment protein, alpha | 0.124 | ||
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.117 | Rat | |
| NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.109 | ||
| HLA-DRB5 | major histocompatibility complex, class II, DR beta 5 | 0.101 | Human | |
| PLAUR | plasminogen activator, urokinase receptor | 0.098 | ||
| NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.077 | ||
| HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | 0.067 | ||
| BCL3 | B-cell CLL/lymphoma 3 | 0.066 | ||
| MAGI2 | membrane associated guanylate kinase, WW and PDZ domain containing 2 | 0.065 | ||
| CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | 0.062 | ||
| CRHR1 | corticotropin releasing hormone receptor 1 | 0.061 | ||
| VAMP3 | vesicle-associated membrane protein 3 (cellubrevin) | 0.056 | ||
| SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.050 | ||
| IL1RAP | interleukin 1 receptor accessory protein | 0.043 | ||
| PPP2CB | protein phosphatase 2, catalytic subunit, beta isozyme | 0.043 | ||
| MPDZ | multiple PDZ domain protein | 0.039 | ||
| PRKAR1A | protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1) | 0.038 | ||
| IRF2 | interferon regulatory factor 2 | 0.036 | ||
| REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 0.032 | ||
| HDAC1 | histone deacetylase 1 | 0.031 | ||
| PPP2R2A | protein phosphatase 2, regulatory subunit B, alpha | 0.029 | ||
| NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.027 | ||
| IL1RN | interleukin 1 receptor antagonist | 0.027 | ||
| S100B | S100 calcium binding protein B | 0.026 | ||
| NR2E3 | nuclear receptor subfamily 2, group E, member 3 | 0.025 | ||
| PRDX1 | peroxiredoxin 1 | 0.024 | ||
| PLAT | plasminogen activator, tissue | 0.023 | ||
| HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 | 0.022 | ||
| RNASE4 | ribonuclease, RNase A family, 4 | 0.022 | ||
| HLA-DPB1 | major histocompatibility complex, class II, DP beta 1 | 0.022 | ||
| HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 | 0.022 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.022 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.021 | ||
| MKL1 | megakaryoblastic leukemia (translocation) 1 | 0.021 | ||
| RANBP9 | RAN binding protein 9 | 0.021 | ||
| HLA-DMB | major histocompatibility complex, class II, DM beta | 0.020 | ||
| MIF | macrophage migration inhibitory factor (glycosylation-inhibiting factor) | 0.020 | ||
| PSEN2 | presenilin 2 (Alzheimer disease 4) | 0.020 | ||
| ARRB2 | arrestin, beta 2 | 0.019 | ||
| HCFC1 | host cell factor C1 (VP16-accessory protein) | 0.019 | ||
| NME2 | non-metastatic cells 2, protein (NM23B) expressed in | 0.019 | Rat | |
| HDAC3 | histone deacetylase 3 | 0.019 | ||
| MGEA5 | meningioma expressed antigen 5 (hyaluronidase) | 0.018 | ||
| HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 | 0.018 | Human | |
| NME1 | non-metastatic cells 1, protein (NM23A) expressed in | 0.015 | ||
| PRKACA | protein kinase, cAMP-dependent, catalytic, alpha | 0.014 | ||
| MAPK10 | mitogen-activated protein kinase 10 | 0.014 | ||
| RYR2 | ryanodine receptor 2 (cardiac) | 0.014 | ||
| PPP2R1A | protein phosphatase 2, regulatory subunit A, alpha | 0.014 | ||
| AKAP11 | A kinase (PRKA) anchor protein 11 | 0.014 | ||
| MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 0.013 | ||
| ABCC8 | ATP-binding cassette, sub-family C (CFTR/MRP), member 8 | 0.013 | ||
| OSMR | oncostatin M receptor | 0.012 | ||
| SMAD3 | SMAD family member 3 | 0.012 | ||
| PPP3R1 | protein phosphatase 3, regulatory subunit B, alpha | 0.012 | ||
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.012 | ||
| MSN | moesin | 0.012 | ||
| NME3 | non-metastatic cells 3, protein expressed in | 0.012 | ||
| NME4 | non-metastatic cells 4, protein expressed in | 0.011 | ||
| MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.011 | ||
| GNAQ | guanine nucleotide binding protein (G protein), q polypeptide | 0.010 | ||
| CCT8 | chaperonin containing TCP1, subunit 8 (theta) | 0.010 | ||
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.010 | ||
| SMAD2 | SMAD family member 2 | 0.010 |